ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $508,800 | -90.4% | 320,000 | -94.3% | 0.06% | -92.1% |
| Q3 2022 | $5,308,000 | +438.3% | 5,587,789 | +5488.2% | 0.72% | +305.1% |
| Q1 2021 | $986,000 | -33.1% | 99,992 | -26.5% | 0.18% | -8.2% |
| Q4 2020 | $1,474,000 | -60.7% | 135,992 | -62.7% | 0.19% | -90.2% |
| Q3 2020 | $3,753,000 | -17.8% | 364,349 | +66.6% | 1.99% | -23.6% |
| Q2 2020 | $4,566,000 | +48.9% | 218,723 | -30.3% | 2.60% | -27.1% |
| Q1 2020 | $3,067,000 | -22.3% | 313,900 | -8.4% | 3.57% | -6.3% |
| Q4 2019 | $3,949,000 | – | 342,800 | – | 3.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |